Silicon Laboratories (NASDAQ:SLAB) SVP Brandon Tolany Sells 1,800 Shares

Silicon Laboratories, Inc. (NASDAQ:SLAB) SVP Brandon Tolany sold 1,800 shares of the firm’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $133.57, for a total value of $240,426.00. Following the completion of the sale, the senior vice president owned 62,328 shares of the company’s stock, valued at approximately $8,325,150.96. This trade represents a 2.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Brandon Tolany also recently made the following trade(s):

• On Friday, August 22nd, Brandon Tolany sold 8,000 shares of Silicon Laboratories stock. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00.
• On Tuesday, August 19th, Brandon Tolany sold 2,270 shares of Silicon Laboratories stock. The shares were sold at an average price of $132.69, for a total value of $301,206.30.

Silicon Laboratories Trading Down 3.0%

Shares of SLAB stock traded down $4.06 during trading on Tuesday, hitting $130.29. The company’s stock had a trading volume of 369,765 shares, compared to its average volume of 402,755. Silicon Laboratories, Inc. has a 52 week low of $82.82 and a 52 week high of $160.00. The company has a market cap of $4.27 billion, a PE ratio of -40.46 and a beta of 1.52. The business has a fifty day moving average of $138.68 and a 200-day moving average of $127.25.

Silicon Laboratories (NASDAQ:SLAB) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The firm had revenue of $192.85 million for the quarter, compared to analysts’ expectations of $192.57 million. During the same period in the prior year, the firm posted ($0.56) earnings per share. The company’s quarterly revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, research analysts predict that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on SLAB shares. Wall Street Zen raised Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, May 14th. Barclays increased their price objective on Silicon Laboratories from $100.00 to $130.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 5th. KeyCorp raised their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, July 8th. Morgan Stanley decreased their price target on Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 6th. Finally, Susquehanna lifted their target price on Silicon Laboratories from $110.00 to $150.00 and gave the stock a “neutral” rating in a report on Tuesday, July 22nd. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $151.13.

Institutional Investors Weigh In On Silicon Laboratories

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. First Trust Advisors LP increased its position in shares of Silicon Laboratories by 25.6% in the 4th quarter. First Trust Advisors LP now owns 2,638 shares of the semiconductor company’s stock valued at $328,000 after purchasing an additional 538 shares during the last quarter. Northern Trust Corp grew its position in shares of Silicon Laboratories by 12.5% during the fourth quarter. Northern Trust Corp now owns 415,007 shares of the semiconductor company’s stock worth $51,552,000 after buying an additional 46,109 shares in the last quarter. Schonfeld Strategic Advisors LLC grew its stake in Silicon Laboratories by 21.6% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 3,914 shares of the semiconductor company’s stock worth $486,000 after buying an additional 696 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Silicon Laboratories by 9.9% during the 4th quarter. Ameriprise Financial Inc. now owns 37,992 shares of the semiconductor company’s stock valued at $4,719,000 after purchasing an additional 3,436 shares during the period. Finally, Balyasny Asset Management L.P. lifted its stake in Silicon Laboratories by 49.4% during the fourth quarter. Balyasny Asset Management L.P. now owns 52,235 shares of the semiconductor company’s stock valued at $6,489,000 after buying an additional 17,267 shares in the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.